V5 Ultimate
Ultimate
PricingResourcesCompany
English (original)العربيةDeutschΕλληνικάEspañolFrançaisItalianoעברית日本語한국어NederlandsPolskiPortuguêsSvenska
Talk to us Log in Start free trial
Food & Beverage
  • Bakery & Confectionery
  • Food Processing
  • Ingredients & Dry Mixes
  • Sausage & Meat Products
  • Produce Packing
  • Pet Food & Pet Supplements
  • Dairy & Chilled Foods
  • Beverages & Liquid Manufacturing
  • Infant Formula
Pharma & Life Sciences
  • Radiopharmaceuticals
  • Pharmaceutical
  • Medical Devices
  • Veterinary Pharmaceuticals
  • Blood & Tissue
  • Diagnostics & IVD Kits
  • Reference Materials & Standards
  • OTC Topical Creams & Gels
Supplements & Personal Care
  • Dietary Supplements
  • Cosmetics & Personal Care
  • Cannabis & Hemp Manufacturing
  • Fragrances & Perfumery
  • Soaps & Personal Hygiene
  • Botanical Extracts & Essential Oils
Chemicals & Materials
  • Plastics & Resins
  • Agricultural Chemicals
  • Specialty & Industrial Chemicals
  • Printing Inks, Pigments & Construction Chemicals
  • Lubricants & Metalworking Fluids
  • Coatings, Adhesives & Sealants
Other Manufacturing
  • Consumer Products
  • Electronics & Electrical Assembly
  • Textiles & Nonwoven
  • Contract Manufacturing & Co-Packing
  • Packaging & Food-Contact Materials
  • Regulated Warehousing & Distribution
Explore all industries
  • Warehouse & TraceabilityReceive, store, pick and trace
  • Production & PlanningPlan jobs and guide production
  • Quality & LaboratoryTest, investigate and review
  • Documents & TrainingControl procedures and qualifications
  • Equipment & PerformanceMaintain assets and measure losses
  • Orders & IntegrationsConnect customers, suppliers and systems
  • Outputs & InsightsReports, KPIs and label design
Why V5? Product & Features
Why V5?Product & Features
  • Warehouse & TraceabilityReceive, store, pick and trace
  • Production & PlanningPlan jobs and guide production
  • Quality & LaboratoryTest, investigate and review
  • Documents & TrainingControl procedures and qualifications
  • Equipment & PerformanceMaintain assets and measure losses
  • Orders & IntegrationsConnect customers, suppliers and systems
  • Outputs & InsightsReports, KPIs and label design
Explore all industries
    • Bakery & Confectionery
    • Food Processing
    • Ingredients & Dry Mixes
    • Sausage & Meat Products
    • Produce Packing
    • Pet Food & Pet Supplements
    • Dairy & Chilled Foods
    • Beverages & Liquid Manufacturing
    • Infant Formula
    • Radiopharmaceuticals
    • Pharmaceutical
    • Medical Devices
    • Veterinary Pharmaceuticals
    • Blood & Tissue
    • Diagnostics & IVD Kits
    • Reference Materials & Standards
    • OTC Topical Creams & Gels
    • Dietary Supplements
    • Cosmetics & Personal Care
    • Cannabis & Hemp Manufacturing
    • Fragrances & Perfumery
    • Soaps & Personal Hygiene
    • Botanical Extracts & Essential Oils
    • Plastics & Resins
    • Agricultural Chemicals
    • Specialty & Industrial Chemicals
    • Printing Inks, Pigments & Construction Chemicals
    • Lubricants & Metalworking Fluids
    • Coatings, Adhesives & Sealants
    • Consumer Products
    • Electronics & Electrical Assembly
    • Textiles & Nonwoven
    • Contract Manufacturing & Co-Packing
    • Packaging & Food-Contact Materials
    • Regulated Warehousing & Distribution
PricingResourcesCompany
Start free trial Log in Talk to us
HomeGlossaryICH Stability Zones (IVb Hot-Humid)
Quality · The complete guide

ICH Stability Zones (IVb Hot-Humid)

In short

Climatic Zone IVb (30°C/75% RH) is the hot, very-humid long-term stability condition used for ASEAN, Caribbean, and similar markets; supplements are not ICH-regulated, but 21 CFR 111 firms that claim a shelf-life or best-by date need data that actually supports it for the climates where the product is sold and stored.

2,659 words · ~13 min read
Scientist places supplement bottles into a stability chamber
Stored conditions should match the markets and the shelf-life claim. Editorial illustration; not a customer photograph.
On this page
  1. 01What climatic Zone IVb is
  2. 02ICH Q1F withdrawal and the current ICH Q1 revision
  3. 03Why supplements are not ICH-regulated, and what applies instead
  4. 04Long-term, intermediate, and accelerated conditions
  5. 05Packaging and moisture control under Zone IVb conditions
  6. 06Designing a protocol for Zone IVb markets
  7. 07Handling out-of-specification and out-of-trend results
  8. 08Expiry and best-by claims: what they mean for a supplement label
  9. 09Records and retention
On this page · 9 sections
  1. 1What climatic Zone IVb is
  2. 2ICH Q1F withdrawal and the current ICH Q1 revision
  3. 3Why supplements are not ICH-regulated, and what applies instead
  4. 4Long-term, intermediate, and accelerated conditions
  5. 5Packaging and moisture control under Zone IVb conditions
  6. 6Designing a protocol for Zone IVb markets
  7. 7Handling out-of-specification and out-of-trend results
  8. 8Expiry and best-by claims: what they mean for a supplement label
  9. 9Records and retention
AI · Explain it for MY operation

How does ICH Stability Zones (IVb Hot-Humid) apply to your shop floor?

Pick your industry and scale — Ask V5 rewrites the definition in your context, gives a worked example, and shows what V5 does on day one.

Your scale

01What climatic Zone IVb is

Pharmaceutical stability guidance groups the world into climatic zones based on mean annual temperature and humidity, so a manufacturer can choose storage conditions that actually represent where a product will be distributed. The commonly used scheme runs from Zone I (temperate, roughly 21°C/45% RH) and Zone II (25°C/60% RH, the historic US/EU long-term condition) through Zone III (hot, dry, roughly 30°C/35% RH) to Zone IVa (hot, humid, 30°C/65% RH) and Zone IVb (hot, very humid, 30°C/75% RH). Zone IVb covers parts of Southeast Asia, West and Central Africa, and parts of Latin America and the Caribbean.

WHO's Technical Report Series No. 953 (2009), Annex 2, 'Stability testing of active pharmaceutical ingredients and finished pharmaceutical products,' is the reference document most often cited for this zone scheme, and it includes an Appendix 1 table listing a confirmed long-term stability testing condition by WHO member state, last updated in March 2021. Many countries in that table are assigned 30°C/75% RH as their confirmed long-term condition, which is the operational definition of Zone IVb for registration purposes in those markets.

The zone system was developed for drug substances and drug products under ICH and WHO frameworks. It did not originate as, and is not, a dietary supplement regulation. Supplement manufacturers who sell into Zone IVb climates use the same physical logic — heat and humidity accelerate moisture uptake, oxidation, and microbial risk — but they are applying it voluntarily as a design reference, not meeting an ICH or WHO legal obligation.

02ICH Q1F withdrawal and the current ICH Q1 revision

ICH previously had a guideline, Q1F, that addressed stability data package requirements for climatic Zones III and IV. ICH withdrew Q1F. Following that withdrawal, ICH published a short statement on its website pointing users to WHO's Annex 2 (TRS 953) for Zone III/IV stability conditions, in effect deferring to the WHO document rather than maintaining its own Zone III/IV guideline. This history is confirmed by WHO's own TRS 1010, Annex 10 (2018) background text, which states that as a result of the 2009 Annex 2 guidance and related discussions, 'the ICH parties withdrew one of their guidance texts (Q1F) and published the following text on their website.' Firms citing Zone IVb requirements should cite WHO Annex 2/Appendix 1, not a current ICH Q1F document, since Q1F no longer exists as an active ICH guideline.

ICH Q1 is being rewritten — check the current step before citing it

ICH endorsed a consolidated draft ICH Q1 guideline, 'Stability Testing of Drug Substances and Drug Products,' at Step 2 of the ICH process on 11 April 2025. This draft is intended to supersede the existing Q1A(R2), Q1B, Q1C, Q1D, Q1E and Q5C guidelines once finalized. As of the most recent public information reviewed for this article, Q1 remains at Step 2/under regional consultation (EMA's public consultation on the draft closed 30 July 2025; FDA issued a corresponding draft guidance for comment in 2025). It has not reached Step 4 (final ICH harmonization) or been adopted as a binding regional guideline. Confirm the current ICH step directly on ich.org before relying on any specific numeric condition from the draft, because conditions could change before finalization.

Because the draft Q1 is not finalized, the long-term Zone IVa (30°C/65% RH) and Zone IVb (30°C/75% RH) conditions in current use trace to ICH Q1A(R2) practice as adopted regionally and to the WHO Annex 2 appendix table, not to a new finalized ICH Q1 text. Track the ICH Q1 work plan if your product is distributed into markets whose regulators may adopt the revised guideline once it reaches Step 4.

03Why supplements are not ICH-regulated, and what applies instead

ICH guidelines, including the Q1 series, are written for medicinal products — drug substances and drug products subject to marketing authorization in the ICH regions. Dietary supplements marketed in the United States are regulated under the Dietary Supplement Health and Education Act framework and FDA's current good manufacturing practice regulation for dietary supplements, 21 CFR Part 111, not under drug GMP or ICH stability guidelines.

21 CFR 111 does not mandate that a manufacturer establish or label an expiration date. However, the regulation requires that if a manufacturer chooses to use an expiration date, it must have data to support that the product, as formulated, packaged, and stored, remains within its established specifications through that date. In practice this means: dating is optional, but once a firm puts a 'best by,' 'use by,' or expiration date on a label, it has taken on a recordkeeping and evidentiary burden to support that date with representative testing. Quality control personnel also remain responsible under Part 111 for determining whether to establish expiration dates and ensuring associated specifications are met.

Applying ICH- and WHO-style climatic zone conditions to a supplement stability program is a reasonable, widely used reference practice for building that supporting data, not a legal requirement. A firm selling exclusively within Zone II climates does not need Zone IVb data to meet 21 CFR 111; a firm distributing into ASEAN markets, the Caribbean, or similarly hot and humid regions has a sound, risk-based reason to include Zone IVb-equivalent long-term conditions, because that is representative of the environment the product will actually experience in transit, storage, and retail.

04Long-term, intermediate, and accelerated conditions

Study typeTypical condition referencedRole in a supplement program
Long-term — Zone II25°C/60% RHRepresents temperate markets; commonly the baseline for US-only distribution.
Long-term — Zone IVa30°C/65% RHRepresents hot, humid markets (e.g., parts of South Asia, parts of Latin America).
Long-term — Zone IVb30°C/75% RHRepresents hot, very humid markets (e.g., ASEAN, Caribbean, parts of West/Central Africa); the most demanding commonly used long-term condition.
Intermediate30°C/65% RHUsed when an accelerated result shows a significant change, to judge whether that change predicts a real long-term risk.
Accelerated40°C/75% RHUsed to stress the product and generate an early signal before long-term data matures; not a substitute for long-term data.

These numeric conditions originate in ICH Q1A(R2) long-term/intermediate/accelerated structure and are echoed in the WHO Annex 2 appendix table by member state. A supplement firm distributing only domestically in a temperate climate has limited reason to run Zone IVb conditions; a firm whose product sits in a non-climate-controlled warehouse or retail shelf in a hot, humid country has a direct quality reason to do so, independent of any regulatory mandate, because accelerated-only data at 40°C/75% RH for a few months does not demonstrate what happens to a hygroscopic ingredient over 18–24 months at 30°C/75% RH.

Selecting the applicable long-term condition should follow the most climatically demanding market the product is actually sold into, not the market where the company is headquartered. A product labeled with a single best-by date for global distribution should be supported by data from the most demanding zone among its intended markets.

05Packaging and moisture control under Zone IVb conditions

At 75% relative humidity, moisture ingress is the dominant stress for many supplement dosage forms: capsule shell brittleness or softening, tablet disintegration or hardness drift, powder caking, probiotic or enzyme potency loss, and softgel leakage or fusion are all humidity-sensitive failure modes. The finished-product container closure — not just the raw material — determines how much of that ambient humidity actually reaches the product, so stability studies should run in the same primary packaging, including desiccant and induction-seal configuration, that will ship to market.

Water-activity and moisture-content specifications are often more informative leading indicators than potency alone for these failure modes, because potency loss frequently lags visible physical degradation. A stability protocol built only around label-claim assay, without moisture or water-activity tracking, can miss a packaging failure until it has already affected a large volume of product in the field.

Where a single container-closure system is used across multiple pack sizes or fill weights, bracketing — testing only the smallest and largest configurations and inferring the intermediate sizes — can reduce the testing burden, provided the rationale documents why the intermediate configurations are expected to behave similarly with respect to headspace and surface-area-to-volume ratio.

06Designing a protocol for Zone IVb markets

A workable protocol for a product claiming shelf life into Zone IVb markets typically documents: the specific finished-product lots and manufacturing dates represented, the exact primary packaging and closure system under test, the storage chamber conditions and tolerances, the test methods and acceptance criteria drawn from the product's established specifications, the sampling and pull-point schedule, and the person(s) responsible for review and disposition of each result.

  • Select representative batches — not only the batch with the cleanest initial results.
  • Use the actual label claim and specification limits as acceptance criteria, not a tighter internal target that was never communicated to QC.
  • Record chamber temperature/humidity logs, not just the nominal setpoint, since excursions affect interpretation of borderline results.
  • Define in advance how an out-of-specification or out-of-trend result at an interim pull point will be investigated and who makes the disposition decision.
  • Keep the rationale for any bracketing, matrixing, or reduced design in the protocol itself, not only in an analyst's notebook.

Pull points are commonly spaced to catch degradation early rather than only confirming the end date: typical intervals are 0, 3, 6, 9, 12, 18, and 24 months for long-term studies, and 0, 1, 2, 3, and 6 months for accelerated studies, adjusted to the proposed shelf life and the degradation profile already known for the formulation. A protocol with only an initial and a final time point cannot demonstrate a trend and makes it difficult to defend an intermediate failure investigation.

07Handling out-of-specification and out-of-trend results

An out-of-specification (OOS) result is a stability test result that falls outside the approved specification limit at a given pull point. An out-of-trend (OOT) result is one that, while still within specification, deviates from the pattern established by prior time points in a way that suggests the product will fail before the proposed shelf life, or that an atypical event occurred. Under 21 CFR 111, firms must establish and follow written procedures for product complaints and quality control, and must investigate and document the cause of any failure to meet specifications; a stability failure that affects a dated claim should be handled through that same documented investigation process, including an assessment of whether other batches sharing the same risk are affected.

A Zone IVb program surfaces OOS/OOT risk earlier than a Zone II-only program would, because the higher humidity stresses moisture-sensitive formulations faster. Treat that as useful early warning rather than as evidence the product is unsuitable for market: an OOT trend at 18 months under 30°C/75% RH, caught before the proposed shelf-life date, is the stability program doing its job, provided the finding is investigated and the labeled date adjusted if the data no longer supports it.

08Expiry and best-by claims: what they mean for a supplement label

FDA does not require dietary supplement labels to carry an expiration, best-by, or use-by date. A firm may choose not to date its product at all. If a firm does include such a date, 21 CFR 111 requires that the date be supported: the firm needs documentation showing the product continues to meet its established specifications, under representative storage and packaging conditions, through the date on the label. There is no fixed ICH-style '24-month' or '36-month' default for supplements; the supportable duration is whatever the data for that specific formulation, packaging, and target climate actually shows.

'Expiration date' and 'best-by date' are not interchangeable regulatory terms with different legal meaning for supplements the way they can be in some food contexts; for supplements the key requirement is simply that any dated claim on the label be substantiated by stability data appropriate to the claim, retained as part of the firm's required records, and available for review.

A supplement intended for Zone IVb distribution that only carries data generated under Zone II conditions has a labeling and evidentiary gap: the date on the carton may not be supportable for the climate the product is actually sold into. Conversely, a firm that never claims a dated shelf life for that market removes the obligation to hold Zone IVb-specific data, but may face retailer or import requirements that effectively require a dated claim anyway, so the commercial reality often drives the testing decision even where federal law does not strictly require it.

09Records and retention

21 CFR 111 requires that records supporting a dietary supplement's identity, purity, strength, composition, and any limits such as those used to support a dated shelf-life claim, be kept and be readily available for FDA review. For a stability program this means retaining the written protocol, the chamber qualification and monitoring records, raw analytical data for each pull point, the investigation records for any OOS or OOT result, and the final conclusion connecting the data to the labeled date. Records should be retrievable as a connected set tied to the specific product lot and packaging configuration they support, rather than as disconnected spreadsheets that cannot later be matched to a labeling decision.

How V5 Ultimate can help

V5 can store stability protocols, pull-point results, and OOS/OOT investigation records against the specific product and packaging lot they apply to, so a labeled best-by date stays traceable to the data that supports it. This is a general document-and-record organization capability; it does not set stability conditions, perform testing, or determine whether a given shelf-life claim is scientifically supportable.

Frequently asked questions

Q.Does the FDA require dietary supplements to be tested at Zone IVb conditions (30°C/75% RH)?+

No. 21 CFR 111 does not mandate any specific climatic test condition, and it does not require an expiration date at all. Zone IVb testing is a voluntary, risk-based practice for firms distributing into hot, very humid markets, borrowed from pharmaceutical stability guidance.

Q.What happened to ICH Q1F, the old guideline for Zone III/IV stability?+

ICH withdrew Q1F. ICH subsequently directed users to WHO's Technical Report Series No. 953, Annex 2 (and its Appendix 1 country table) for climatic Zone III/IV stability conditions instead of maintaining its own Zone III/IV-specific guideline.

Q.Is ICH Q1 currently being revised?+

Yes. ICH endorsed a consolidated draft Q1 guideline at Step 2 on 11 April 2025, intended to replace the existing Q1A(R2), Q1B, Q1C, Q1D, Q1E, and Q5C guidelines. As of the most recent information reviewed, it remained at Step 2/regional consultation and had not reached Step 4 final harmonization; check ich.org directly for the current status before citing specific provisions.

Q.If my supplement doesn't carry an expiration date, do I still need stability data?+

21 CFR 111 does not require stability data purely to omit a date. However, quality control personnel are still responsible for determining specifications and whether dating is appropriate, and many firms generate some stability data to support formulation and packaging decisions even without a label date.

Q.What's the difference between an OOS and an OOT result in a stability study?+

An OOS result falls outside the approved specification limit at a given time point. An OOT result stays within specification but deviates from the established trend in a way that suggests the product may not hold through the proposed shelf life, or that something atypical happened at that pull point. Both warrant documented investigation.

Q.Can I use one global best-by date if I sell into both temperate and Zone IVb markets?+

Only if the data supporting that date was generated under conditions representative of the most climatically demanding market the date applies to. A single global date supported only by Zone II data would not be supportable for Zone IVb distribution.

Q.Are supplements subject to ICH guidelines at all?+

No. ICH guidelines, including the Q1 series, apply to medicinal products subject to marketing authorization in ICH regions. Supplements fall under 21 CFR 111 and related FDA/FTC labeling and claims rules in the US; ICH and WHO stability concepts are used only as voluntary reference practice.

Primary sources

  • WHO Technical Report Series No. 953, Annex 2 — Stability testing of APIs and FPPs — reviewed 9 Oct 2026
  • WHO TRS 953 Annex 2, Appendix 1 — Stability conditions for WHO Member States by Region (updated March 2021) — reviewed 9 Oct 2026
  • WHO TRS 1010, Annex 10 — background noting ICH withdrawal of Q1F — reviewed 9 Oct 2026
  • EMA — ICH Q1 guideline on stability testing of drug substances and drug products (Step 2b draft status) — reviewed 9 Oct 2026
  • FDA — Q1 Stability Testing of Drug Substances and Drug Products, draft guidance — reviewed 9 Oct 2026
  • eCFR — 21 CFR Part 111, Current Good Manufacturing Practice for Dietary Supplements — reviewed 9 Oct 2026

Further reading

  • Dietary Supplement Operations Guide
    21 CFR 111 operational context for records, specifications, and quality control decisions referenced in this article.
  • Reference Materials Guide
    Background on reference standards and documentation practices relevant to stability testing records.
Software that covers ICH Stability Zones (IVb Hot-Humid)
V5 Ultimate LIMS
V5 includes laboratory information management alongside production and quality: sample plans, requests, lab queues and results…
V5 Ultimate Dietary Supplements
Written for supplement contract manufacturers and brand owners tired of surviving FDA 483s on paper.
Talk to us about ICH Stability Zones (IVb Hot-Humid)

Want to see how ICH Stability Zones (IVb Hot-Humid) could fit into your own records and workflows? Explore the related V5 pages or talk to our team about what applies to your operation.

Start free
Back to glossary
Inside V5
  • → QMS — quality records next to the work they concern.
  • → Document control — one version in force, every change signed and explained.
Regulatory anchors
  • ICH Q1A(R2)
  • ICH Q1F
Related terms
  • → Bracketing & Matrixing (ICH Q1D)
  • → Supplement Stability & Shelf Life
  • → ICH Q1A
  • → ICH Q1A Stability Storage Conditions

Next Step

Try V5 with your own records, or ask a question first. Ask V5 opens with an editable question; nothing is sent until you choose to.

Start your free trial Browse All Features

Showing the site for the United States. Local spelling, dates and prices are applied automatically; change the language at the top of the page.

V5 Ultimate
Ultimate

Warehouse, quality and manufacturing software for regulated operations.

ProductIndustriesPricingResourcesSecurity & TrustCompanyLegal Centre

© S.G. Systems, LLC